Most health policy experts expect hospital price caps to reduce healthcare spending, but many also see potential tradeoffs for hospital finances, access and quality as more states pursue limits on commercial reimbursement.
Seventy-five percent of members of the Cornell Health Policy Center Insight Panel agreed or strongly agreed that states capping commercial hospital prices — for example, at 150% of Medicare — would see substantial reductions in total healthcare costs, according to a Sept. 30 analysis published in Health Affairs. Sixty-one of the panel’s 65 experts responded to the survey.
The findings come as hospital price caps move from policy debate to reality in a growing number of states. More than a dozen states have enacted or are advancing policies restricting what hospitals can charge commercial payers, often by tying rates to a multiple of Medicare reimbursement.
The experts surveyed by Cornell broadly agreed on the potential for price caps to lower spending, but several raised questions about whether those savings could come with unintended consequences. Panelists pointed to potential pressure on access and quality, implementation challenges and the possibility that hospitals could increase higher-margin services to offset lost revenue.
Oregon provides one of the clearest early tests.
The state capped hospital payments for its employee health plan at 200% of Medicare beginning in 2019. Research cited by Health Affairs found the policy generated about $50 million in annual savings and reduced out-of-pocket spending for members by 9.5%. A Brown University analysis found no statistically significant effect on hospital net patient revenue, patient care expenses or operating margins, nor evidence of service-line closures, staffing reductions or clinician pay cuts tied to the Oregon cap.
But the policy covered only about 15% of commercially insured patients, making it difficult to extrapolate the findings to broader statewide caps. That distinction is becoming increasingly important as states consider more expansive policies.
Indiana and Vermont became among the first states to enforce systemwide commercial hospital price restrictions in 2025. Delaware has since approved legislation phasing in Medicare-based caps, while Michigan has considered a proposal that would cap reimbursement at 200% of Medicare and require hospitals to immediately reduce prices by 10%.
Hospital leaders have warned that the speed and scope of those changes matter.
Burlington, Vt.-based UVM Health has been working through a combination of state pricing and budget policies that removed about $220 million, or roughly 10%, from UVM Medical Center’s annual revenue. The system is pursuing $300 million in expense reductions over three years. Meanwhile, commercial insurance rates fell an average of 12% in 2026 and MRI and CT prices dropped 25%, UVM Health President and CEO Stephen Leffler, MD, previously told Becker’s.
In Michigan, MyMichigan Health CEO Bryan Cross, PharmD, has said a 200%-of-Medicare cap could force the system to reconsider how it deploys resources across rural markets, where lower patient volumes and longer travel distances already make service delivery more difficult. The Midland-based system’s long-term goal is to reach breakeven on Medicare and Medicaid, which Mr. Cross said becomes increasingly important if commercial reimbursement is constrained.
The Cornell panel was less unified on other affordability strategies.
Thirty-nine percent agreed that reference pricing for shoppable services such as imaging and joint replacements would substantially reduce employee insurance premiums, compared with 31% who disagreed and 30% who were uncertain or did not know. Nearly two-thirds, or 66%, agreed that stronger federal antitrust enforcement limiting new hospital mergers would substantially slow healthcare price growth in affected markets.
Some panelists questioned how much impact blocking future mergers could have given the level of consolidation that already exists in many hospital markets. The findings highlight the tension facing hospital leaders as price caps spread: The policies may reduce commercial healthcare spending, but their broader effects will depend on how aggressively rates are capped, how much of the market is affected and whether hospitals can absorb the revenue reduction without cutting access, workforce or investment.
Click here to read the Health Affairs report.
